MetLife, Inc. (MET) Lowered to Hold at Sandler O’Neill

Sandler O’Neill downgraded shares of MetLife, Inc. (NYSE:MET) from a buy rating to a hold rating in a research note released on Friday morning.

Other research analysts also recently issued reports about the company. Langen Mcalenn restated a buy rating on shares of MetLife in a research note on Wednesday, August 16th. ValuEngine downgraded MetLife from a strong-buy rating to a buy rating in a research note on Thursday. B. Riley restated a neutral rating on shares of MetLife in a research note on Monday, November 6th. Keefe, Bruyette & Woods restated a buy rating and set a $59.00 target price on shares of MetLife in a research note on Thursday, August 3rd. Finally, Zacks Investment Research downgraded MetLife from a hold rating to a sell rating in a research note on Wednesday, August 9th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. The company presently has an average rating of Buy and a consensus price target of $58.40.

Shares of MetLife (MET) traded down $0.61 during trading hours on Friday, hitting $52.20. The stock had a trading volume of 4,853,100 shares, compared to its average volume of 4,040,548. MetLife has a twelve month low of $44.26 and a twelve month high of $55.91. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a market cap of $54,930.01, a P/E ratio of 10.04, a PEG ratio of 1.31 and a beta of 1.51.

MetLife (NYSE:MET) last announced its earnings results on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.19. MetLife had a positive return on equity of 8.81% and a negative net margin of 0.75%. The firm had revenue of $16.10 billion for the quarter, compared to the consensus estimate of $15.47 billion. During the same period in the previous year, the business earned $1.28 EPS. The firm’s revenue for the quarter was up 1.7% on a year-over-year basis. sell-side analysts forecast that MetLife will post 4.43 EPS for the current fiscal year.

WARNING: This article was posted by Markets Daily and is the sole property of of Markets Daily. If you are viewing this article on another website, it was copied illegally and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.themarketsdaily.com/2017/11/13/metlife-inc-met-lowered-to-hold-at-sandler-oneill.html.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 13th. Investors of record on Monday, November 6th will be issued a $0.40 dividend. The ex-dividend date is Friday, November 3rd. This represents a $1.60 dividend on an annualized basis and a yield of 3.07%. MetLife’s payout ratio is -320.00%.

MetLife declared that its board has authorized a share repurchase program on Wednesday, November 1st that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the financial services provider to reacquire shares of its stock through open market purchases. Shares repurchase programs are often a sign that the company’s management believes its stock is undervalued.

In other MetLife news, insider Christopher G. Townsend sold 55,712 shares of the business’s stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the completion of the sale, the insider now directly owns 25,181 shares in the company, valued at approximately $1,367,076.49. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Christopher G. Townsend sold 82,731 shares of the business’s stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $54.60, for a total value of $4,517,112.60. Following the sale, the insider now owns 49,660 shares of the company’s stock, valued at $2,711,436. The disclosure for this sale can be found here. Corporate insiders own 0.32% of the company’s stock.

A number of large investors have recently bought and sold shares of MET. Farmers National Bank purchased a new stake in MetLife during the 2nd quarter worth approximately $118,000. Ffcm LLC increased its stake in MetLife by 2,020.8% during the 3rd quarter. Ffcm LLC now owns 2,248 shares of the financial services provider’s stock worth $119,000 after buying an additional 2,142 shares in the last quarter. Cable Hill Partners LLC increased its stake in MetLife by 246.6% during the 3rd quarter. Cable Hill Partners LLC now owns 2,412 shares of the financial services provider’s stock worth $125,000 after buying an additional 1,716 shares in the last quarter. Westside Investment Management Inc. increased its stake in MetLife by 583.8% during the 1st quarter. Westside Investment Management Inc. now owns 2,694 shares of the financial services provider’s stock worth $140,000 after buying an additional 2,300 shares in the last quarter. Finally, Parallel Advisors LLC increased its stake in MetLife by 50.7% during the 1st quarter. Parallel Advisors LLC now owns 2,748 shares of the financial services provider’s stock worth $143,000 after buying an additional 924 shares in the last quarter. Institutional investors own 73.79% of the company’s stock.

About MetLife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply